Gastric Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Gastric Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-12-18Clinical Trial Update: Oxaliplatin Plus Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Adenocarcinoma [Phase 2]
An update on a Phase 2 trial evaluating perioperative oxaliplatin plus capecitabine for locally advanced gastric adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2015-10-27Clinical Trial Update: Pilot Study of Perioperative Docetaxel, Oxaliplatin, and 5-Fluorouracil (FLOT) in Gastroesophageal Adenocarcinoma [Phase 2]
A Phase 2 pilot study evaluating perioperative chemotherapy with docetaxel, oxaliplatin, and 5-fluorouracil (FLOT) for gastroesophageal aden…
-
CLINICAL_TRIALS trial_result · 2015-10-09Clinical Trial Update: Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types [Phase 2]
Phase II clinical trial of Brivanib (BMS-582664) across multiple tumor types has completed.
-
CLINICAL_TRIALS trial_result · 2015-05-28Clinical Trial Update: Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients
This clinical trial update reports a completed study evaluating induction chemotherapy followed by chemoradiotherapy and surgery in locally …
-
CLINICAL_TRIALS trial_result · 2015-05-19Clinical Trial Update: Trial of ABI-007 Plus S-1 as Second-line Chemotherapy in Advanced Gastric Cancer Patients [Phase 1, Phase 2]
This document provides an update on a phase 1/2 clinical trial evaluating ABI-007 (liposomal irinotecan) in combination with S-1 as second-l…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-03-11Clinical Trial Update: Efficacy and Safety of Panitumumab Combined With Docetaxel and Cisplatin as a First-line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 2]
Phase 2 trial evaluating the efficacy and safety of combining panitumumab with docetaxel and cisplatin as first-line therapy for advanced ga…
-
CLINICAL_TRIALS trial_result · 2015-01-29Clinical Trial Update: ITACA-S2 (Intergroup Trial in Adjuvant Chemotherapy for Adenocarcinoma of the Stomach) [Phase 3]
The ITACA-S2 Phase 3 trial evaluating adjuvant chemotherapy for gastric adenocarcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-11-07Clinical Trial Update: Dose-dense Biweekly Docetaxel Combined With 5-fluorouracil as First-line Treatment in Advanced Gastric Cancer [Phase 2]
A completed Phase 2 trial examined dose-dense biweekly docetaxel plus 5-fluorouracil as first-line treatment for advanced gastric cancer.
-
CLINICAL_TRIALS trial_result · 2014-07-31Clinical Trial Update: A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma [Phase 3]
Phase 3 trial evaluating paclitaxel with or without ramucirumab (IMC-1211B) in metastatic gastric adenocarcinoma has completed and results w…
-
CLINICAL_TRIALS trial_result · 2014-07-04Clinical Trial Update: Perioperative Panitumumab and Epirubicin, Oxaliplatin and Xeloda (EOX) in Patients With Gastroesophageal Adenocarcinoma [Phase 1, Phase 2]
Phase 1/2 perioperative study of panitumumab with EOX chemotherapy in gastroesophageal adenocarcinoma; the trial was terminated with results…
-
CLINICAL_TRIALS trial_result · 2014-06-18Clinical Trial Update: Study of Weekly Paclitaxel With Ramucirumab in Participants With Advanced Gastric Adenocarcinomas [Phase 1]
Phase 1 study evaluating weekly paclitaxel combined with ramucirumab in patients with advanced gastric adenocarcinoma; results were posted i…
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: Study of 5-Fluorouracil and Leucovorin and Intra-abdominal Floxuridine Chemoradiation in Patients With Fully Resected Locally Advanced Gastric Adenocarcinoma [Phase 2]
Phase 2 trial evaluating a chemoradiation regimen of 5-fluorouracil, leucovorin, and floxuridine given with radiation in patients with fully…
-
CLINICAL_TRIALS trial_result · 2014-05-14Clinical Trial Update: Sunitinib in Patients With Advanced Gastric Cancer and Treated With FOLFIRI [Phase 2]
Phase 2 clinical trial update of sunitinib in patients with advanced gastric cancer previously treated with FOLFIRI.
-
CLINICAL_TRIALS trial_result · 2014-03-20Clinical Trial Update: Response Rate and Side Effects of Preoperative Chemotherapy (TOX Regimen) in Patients With Locally Advanced Operable Gastric Adenocarcinoma [Phase 2]
Phase 2 trial evaluating the response rate and safety of the TOX chemotherapy regimen in patients with locally advanced operable gastric ade…
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative Resection [Phase 2]
A Phase II clinical trial evaluating catumaxomab in gastric cancer patients who received neoadjuvant chemotherapy and curative resection has…
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: FR901228 in Treating Patients With Refractory Stomach Cancer or Gastroesophageal Junction Cancer [Phase 2]
A Phase 2 trial of FR901228 in patients with refractory stomach cancer or gastroesophageal junction cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Concurrent Induction Chemoimmunotherapy With Epirubicine, Oxaliplatin, Capecitabine and Panitumumab in KRAs Wild-type, Resectable Type II Gastric Adenocarcinoma [Phase 2]
A Phase 2 trial assessing concurrent induction chemoimmunotherapy with epirubicin, oxaliplatin, capecitabine, and panitumumab in KRAS wild-t…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Docetaxel and S1 (DS) Versus S1 and Cisplatin (SP) in Curatively Resected Stage IIIB/IV Gastric Cancer [Phase 3]
Phase 3 trial comparing docetaxel plus S-1 versus S-1 plus cisplatin in curatively resected stage IIIB/IV gastric cancer. The current status…
-
CLINICAL_TRIALS trial_result · 2013-02-20Clinical Trial Update: Efficacy and Safety Study of Combination Therapy With Docetaxel-oxaliplatin-capecitabine in Patients With Advanced Gastric Adenocarcinoma and Intermediate General Status [Phase 2]
This Phase 2 trial evaluates the efficacy and safety of a docetaxel-oxaliplatin-capecitabine combination in patients with advanced gastric a…
-
CLINICAL_TRIALS trial_result · 2012-12-10Clinical Trial Update: Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers [Phase 2]
Phase 2 trial of irinotecan/cisplatin with potentially curative surgery (with or without floxuridine) followed by capecitabine for gastric a…
-
CLINICAL_TRIALS trial_result · 2012-07-17Clinical Trial Update: Efficacy and Safety Study of ABI-007 Plus Capecitabine as First-line Chemotherapy for Advanced Gastric Cancer Patients [Phase 2]
Phase 2 trial evaluating ABI-007 (nab-paclitaxel) plus capecitabine as first-line chemotherapy for advanced gastric cancer, with an efficacy…
-
CLINICAL_TRIALS trial_result · 2012-03-28Clinical Trial Update: Efficacy and Safety Study of a Modified SOX Regimen in First-Line Treatment of Unresectable Gastric Adenocarcinoma [Phase 2]
Phase 2 trial assessing efficacy and safety of a modified S-1 plus oxaliplatin (SOX) regimen as first-line treatment for unresectable gastri…
-
CLINICAL_TRIALS trial_result · 2012-01-19Clinical Trial Update: A Study of Bevacizumab in Combination With Capecitabine and Cisplatin as First-line Therapy in Patients With Advanced Gastric Cancer [Phase 3]
Phase 3 trial evaluating bevacizumab added to capecitabine and cisplatin as first-line therapy for advanced gastric cancer; results from the…
-
CLINICAL_TRIALS trial_result · 2011-01-14Clinical Trial Update: Efficacy and Safety of Sunitinib in Metastatic Gastric Cancer [Phase 2]
A Phase 2 trial evaluating the efficacy and safety of sunitinib in metastatic gastric cancer (gastric adenocarcinoma) has completed with res…
-
CLINICAL_TRIALS trial_result · 2007-12-31Clinical Trial Update: Phase II Trial of Gleevec and Taxotere as a Combined Regimen for Advanced Gastric Adenocarcinoma [Phase 2]
Phase II trial evaluating a combination of imatinib (Gleevec) and docetaxel (Taxotere) for advanced gastric adenocarcinoma has been terminat…